When a child is diagnosed with cancer, their family is presented with treatment options – often a combination of surgery, radiation and chemotherapy. Radiation and chemotherapy have been used to treat kids’ cancers for more than 50 years and often come with long-term late effects including secondary cancers, heart damage and cognitive issues. Often a child’s best chance at survival is a clinical trial which offers them the newest treatment options available.
In recognition of Childhood Cancer Awareness Month, the St. Baldrick’s Foundation will highlight the critical need to fund lifesaving research and share stories of kids affected by cancer – like Micah, who is alive today because there was a clinical trial available.
To view the multimedia release go to:
https://www.multivu.com/players/English/8284352-st-baldricks-foundation-conquer-childhood-cancers/
Relentless in his lifelong devotion to the elephants' survival, Save the Elephants founder Iain Douglas-Hamilton, Ph.D., has been named the 2010 recipient of the Indianapolis Prize, the world's leading award for animal conservation. In recognition for his lifetime achievements, Dr. Douglas-Hamilton will receive $100,000 and the Lilly Medal at a gala ceremony presented by Cummins Inc. on Sept. 25, 2010, at The Westin Hotel in Indianapolis.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/indianapoliszoo/44156/
National Tire Safety Week is an industry-wide initiative that educates drivers about the importance of proper tire care. Summer is the season for road trips, so now is a good time to brush up on your tire maintenance knowledge. Remember though, tire safety is critical all year round.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/7127551-michelin-tire-rack-street-survival-announces-national-program-schedule
We're down to the final five and it's time to test the girls' survival skills. But can they handle the battle and not take it personally? Tune in Wednesday at 11pm ET on FUSE to find out.
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
At 37 years old, with a thriving concrete business, a wife and three young children, dying was the last thing on Travis Roberts’ mind. But after a doctor’s visit for a kidney stone, Roberts learned he had cholangiocarcinoma, a cancer of the bile duct. His survival rate was zero.
Roberts shared his story as part of Northwestern Mutual’s ongoing Client Stories series, which highlights the importance of financial security in the face of life’s most difficult circumstances.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7100753-northwestern-mutual-financial-security-cancer-diagnosis-disability-insurance/
Results from a large retrospective data analysis published in the American Journal of Transplantation (AJT) today, showed that liver transplantation patients who were treated early with Advagraf experienced a significantly increased graft survival benefit of 8% at 3 years post-transplant compared with patients treated with the current standard of care, tacrolimus immediate release (twice daily).
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7451251-advagraf-prolonged-release-tacrolimus/
Human labor is increasingly becoming superfluous in manufacturing operations as robots and fully automated processes take over. The latest technology-based production solutions reduce unit costs and are often the key to manufacturers’ future survival.
Soy consumption is up 14 percent since 2011,26 yet confusion lingers over soy’s role in everything from human health to food production. To clear up misperceptions, the United Soybean Board (USB) busts five common soy myths with science-backed facts on SoyConnection.com/soy-wisdom.
1) Eating soy does not increase breast cancer risk.
Clinical studies show soy isoflavone exposure does not adversely affect breast tissue as assessed by markers of breast cancer risk, such as breast cell proliferation.1–7 The American Institute for Cancer Research and the American Cancer Society say that women who have been diagnosed with breast cancer can safely consume soyfoods. In fact, the World Cancer Research Fund International has identified a link between soy consumption and an improved survival of breast cancer patients.8-9
“Not only does evidence indicate soyfoods may benefit women with breast cancer, but consuming soy when young helps prevent the onset of this disease later in life27-30,” stated Mark Messina, Ph.D., who has dedicated the past 30 years to understanding the health effects of soyfoods.
To view the multimedia release go to:
http://www.multivu.com/players/English/7877951-united-soybean-board-top-soy-myths/
Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and haemodynamic monitoring, announced the results of a pivotal clinical study of high-risk surgical patients with severe aortic stenosis treated in Cohort A of The PARTNER Trial. These data demonstrate that the study achieved its primary endpoint at one year, concluding that survival of patients treated with the Edwards SAPIEN transcatheter aortic valve was equivalent to those treated with surgical aortic valve replacement. The data were presented at the American College of Cardiology’s (ACC) 60th Annual Scientific Session & Expo in New Orleans, LA, USA.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/edwardslifesciences/48895/
Discovery en Español welcomes the new year with adrenaline-filled premieres on its popular programming block ‘Jueves de Aventura,’ highlighting the original production DESAFÍO X 2: MÉXICO, where two survival experts from Colombia and México, will test their skills in inhospitable territories of Chiapas, Veracruz and Puebla. DESAFÍO X 2: MÉXICO premieres January 12 and will air on Thursdays at 11PM E/P.
Each of the six episodes will feature Colombian adventurer Daniel Tirado and Mexican army veteran Alberto Pegueros surviving in extremely remote wild Aztec lands and putting their skills and knowledge into practice in order to make their way back to civilization safe and sound. Together, they have to avoid danger, predators, and find food, water and shelter. However, conflicts are not only limited to wilderness, and each man’s survival skills might not always match those of his partner, so combining techniques and living together could become the greatest of challenges for both men.
To view the multimedia release go to:
http://www.multivu.com/players/English/8010451-discovery-en-espanol-2017-premieres/
Cycle for Survival, the nationwide movement to beat rare cancers, brought hundreds of supporters to Times Square on Friday for its second annual Times Square Takeover, an all-day celebration featuring high-energy stationary cycling sessions.
The day kicked off Cycle for Survival’s ninth year and the launch of registration for its 2015 events across the country.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7325451-cycle-for-survival-second-annual-times-square-takeover-2015-registration-launch/
